Last edition
News about
GST Council Slashes Tax on Medical Devices, Lifesaving Drugs
The Council has reduced GST on a wide range of medical apparatus and devices — used for medical, surgical, dental, or veterinary purposes as well as for physical or chemical analysis — from 18 percent to five percent.
BioNxt Begins Lab-Scale ODF Development After Receiving Semaglutide API
BioNxt Solutions has received the Semaglutide active pharmaceutical ingredient (API), enabling the initiation of laboratory-scale formulation and testing of its oral dissolvable film (ODF) delivery system.
Lupin Secures US FDA Approval for Risperidone Long-Acting Injectable
Lupin has received US FDA approval for its Risperidone extended-release injectable suspension, marking the first product from its Nanomi long-acting injectables platform with 180-day CGT exclusivity.
Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform
Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.
Polpharma Biologics Partners with MS Pharma to Commercialize Biosimilars in MENA Region
Polpharma Biologics S.A., a biotechnology company specializing in the development and manufacturing of biosimilars, has entered into licensing agreements with MS Pharma, a leading biosimilar producer and distributor in the Middle East and North Africa (MENA) region.
Allchem Lifescience Receives SEBI Nod for INR 190 Crore IPO
Allchem Lifescience Limited, a domestic manufacturer specializing in API intermediates and specialty chemicals, has secured approval from the Securities and Exchange Board of India (SEBI) to proceed with its initial public offering (IPO).
Bio X Cell Appoints Cambridge as Exclusive UK and Ireland Distributor
Bio X Cell has appointed Cambridge Bioscience, a member of Europa Biosite, as its exclusive distributor for the United Kingdom and Ireland.
Quotient Sciences and CPI to Form JV to Accelerate RNA Drug Development
Quotient Sciences and UK innovation centre CPI have signed an MoU to form a joint venture that will accelerate the development of RNA-based therapies through an integrated, end-to-end platform.
SeqOne Strengthens UK Presence with Acquisition of Congenica
The acquisition of UK genomics leader Congenica strengthens SeqOne’s market position and global footprint, servicing over 160 labs in more than 30 countries.
Asia-Pacific Emerges as Fastest-Growing Market for Surgical Robotics
The Asia Pacific region is gaining momentum in the global surgical robotics market, with countries like China, India, Japan, and South Korea driving forward the regional surge in demand and deployment.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy